ICU Medical holds 2024 Annual Meeting; all director nominees elected, auditor ratified, say-on-pay approved

ICU MEDICAL INC/DE

All seven director nominees elected: Vivek Jain, David C. Greenberg, Elisha W. Finney, David F. Hoffmeister, Donald M. Abbey, Laurie Hernandez, Kolleen T. Kennedy.
Ratification of Deloitte & Touche as independent auditor for FY 2024 approved with 22,484,283 votes for, 222,466 against.
Advisory vote on named executive officer compensation approved with 20,673,543 votes for, 824,221 against.
Broker non-votes totaled 1,202,538 on director election and say-on-pay proposals.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ICU MEDICAL INC/DE shareholders approved Election of directors at the 2024-05-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

The Company’s stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is elected and qualified.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ICU MEDICAL INC/DE shareholders approved Approve the advisory vote on the Company’s named executive officer compensation at the 2024-05-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation.

View on SEC.gov

Browse all shareholder votes →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-24-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.